Cargando…

Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development

Virus-like particles (VLPs) are a class of subunit vaccines that differentiate themselves from soluble recombinant antigens by stronger protective immunogenicity associated with the VLP structure. Like parental viruses, VLPs can be either non-enveloped or enveloped, and they can form following expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kushnir, Natasha, Streatfield, Stephen J., Yusibov, Vidadi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2012
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115575/ https://www.ncbi.nlm.nih.gov/pubmed/23142589 http://dx.doi.org/10.1016/j.vaccine.2012.10.083

Ejemplares similares

Introduction
por: Streatfield, Stephen J., et al.
Publicado: (2017)

Safety and immunogenicity of a plant-produced Pfs25 virus-like particle as a transmission blocking vaccine against malaria: A Phase 1 dose-escalation study in healthy adults
por: Chichester, Jessica A., et al.
Publicado: (2018)

Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study in Healthy Adults
por: Chichester, Jessica A., et al.
Publicado: (2012)

A launch vector for the production of vaccine antigens in plants
por: Musiychuk, Konstantin, et al.
Publicado: (2007)

Optimization and Utilization of Agrobacterium-mediated Transient Protein Production in Nicotiana
por: Shamloul, Moneim, et al.
Publicado: (2014)

Using transgenic plants and modified plant viruses for the development of treatments for human diseases
por: Loh, Hwei-San, et al.
Publicado: (2017)

Green algae Chlamydomonas reinhardtii possess endogenous sialylated N-glycans
por: Mamedov, Tarlan, et al.
Publicado: (2011)

Platforms, advances, and technical challenges in virus-like particles-based vaccines
por: Gupta, Reeshu, et al.
Publicado: (2023)

Production of Functionally Active and Immunogenic Non-Glycosylated Protective Antigen from Bacillus anthracis in Nicotiana benthamiana by Co-Expression with Peptide-N-Glycosidase F (PNGase F) of Flavobacterium meningosepticum
por: Mamedov, Tarlan, et al.
Publicado: (2016)

Virus-like Particle Vaccines and Platforms for Vaccine Development
por: Kheirvari, Milad, et al.
Publicado: (2023)

Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines
por: Caldeira, Jerri C., et al.
Publicado: (2020)

A plant‐produced influenza subunit vaccine protects ferrets against virus challenge
por: Mett, Vadim, et al.
Publicado: (2008)

Intranasal vaccination with a plant-derived H5 HA vaccine protects mice and ferrets against highly pathogenic avian influenza virus challenge
por: Major, Diane, et al.
Publicado: (2015)

Virus like particles as a platform for cancer vaccine development
por: Ong, Hui Kian, et al.
Publicado: (2017)

Virus-Like Particles, a Versatile Subunit Vaccine Platform
por: Donaldson, Braeden, et al.
Publicado: (2014)

Production of virus-like particles for vaccines
por: Fuenmayor, J., et al.
Publicado: (2017)

Deletions within the 3′ Non-Translated Region of Alfalfa mosaic virus RNA4 Do Not Affect Replication but Significantly Reduce Long-Distance Movement of Chimeric Tobacco mosaic virus
por: Roy, Gourgopal, et al.
Publicado: (2013)

The human potential of a recombinant pandemic influenza vaccine produced in tobacco plants
por: Jul-Larsen, Åsne, et al.
Publicado: (2012)

Virus-Like Particles as an Instrument of Vaccine Production
por: Syomin, B. V., et al.
Publicado: (2019)

Therapeutic monoclonal antibody treatment protects nonhuman primates from severe Venezuelan equine encephalitis virus disease after aerosol exposure
por: Burke, Crystal W., et al.
Publicado: (2019)

Yeast-Based Virus-like Particles as an Emerging Platform for Vaccine Development and Delivery
por: Srivastava, Vartika, et al.
Publicado: (2023)

Recent Advances in the Use of Plant Virus-Like Particles as Vaccines
por: Balke, Ina, et al.
Publicado: (2020)

Epitope-Specific Anti-hCG Vaccines on a Virus Like Particle Platform
por: Caldeira, Jerri, et al.
Publicado: (2015)

Virus-Like Particles: Revolutionary Platforms for Developing Vaccines Against Emerging Infectious Diseases
por: Tariq, Hasnat, et al.
Publicado: (2022)

Efficient expression of enterovirus 71 based on virus-like particles vaccine
por: Kim, Hye-Jin, et al.
Publicado: (2019)

Modular vaccine platform based on the norovirus-like particle
por: Lampinen, Vili, et al.
Publicado: (2021)

A plant‐based system for rapid production of influenza vaccine antigens
por: Shoji, Yoko, et al.
Publicado: (2011)

A Plant-Produced Pfs25 VLP Malaria Vaccine Candidate Induces Persistent Transmission Blocking Antibodies against Plasmodium falciparum in Immunized Mice
por: Jones, R. Mark, et al.
Publicado: (2013)

Recent Advances in the Development of Virus-Like Particle-Based Flavivirus Vaccines
por: Zhang, Naru, et al.
Publicado: (2020)

Development of a Novel Virus-Like Particle Vaccine Platform That Mimics the Immature Form of Alphavirus
por: Urakami, Akane, et al.
Publicado: (2017)

Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development
por: Rodríguez-Limas, William A, et al.
Publicado: (2013)

Hepatitis B core-based virus-like particles: A platform for vaccine development in plants
por: Moradi Vahdat, Maryam, et al.
Publicado: (2021)

Flagellin/Virus-like Particle Hybrid Platform with High Immunogenicity, Safety, and Versatility for Vaccine Development
por: Zhao, Yiwen, et al.
Publicado: (2022)

Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus
por: Mazalovska, Milena, et al.
Publicado: (2020)

Efficient oral vaccination by bioengineering virus-like particles with protozoan surface proteins
por: Serradell, Marianela C., et al.
Publicado: (2019)

Improved Production Efficiency of Virus-Like Particles by the Baculovirus Expression Vector System
por: López-Vidal, Javier, et al.
Publicado: (2015)

Engineering a Virus-Like Particle as an Antigenic Platform for a Pfs47-Targeted Malaria Transmission-Blocking Vaccine
por: Yenkoidiok-Douti, Lampouguin, et al.
Publicado: (2019)

Developing a platform system for gene delivery: amplifying virus-like particles (AVLP) as an influenza vaccine
por: Wei, Huiling, et al.
Publicado: (2017)

Virus-Like Particle and Nanoparticle Vaccines
por: Kanekiyo, M., et al.
Publicado: (2017)

Bacterial superglue enables easy development of efficient virus-like particle based vaccines
por: Thrane, Susan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t5hjgncj5et5st0drsnjtupcpq